Skip to main content

High peak estradiol/mature oocyte ratio predicts lower clinical pregnancy, ongoing pregnancy, and live birth rates in GnRH antagonist intracytoplasmic sperm injection cycles

Publication ,  Journal Article
Sandoval, JS; Steward, RG; Chen, C; Li, YJ; Price, TM; Muasher, SJ
Published in: Journal of Reproductive Medicine
February 1, 2016

OBJECTIVE: To define the relationship between peak estradiol (E2)/mature oocyte ratio and pregnancy outcomes in gonadotropin-releasing hormone (GnRH) antagonist intracytoplasmic sperm injection (ICSI) cycles. STUDY DESIGN: Retrospective cohort study in the setting of an academic re-productive medicine practice. Records from 162 fresh, autologous, GnRH antagonist ICSI cycles performed between 2009 and 2012 were analyzed. The main outcome measures were rates of clinical pregnancy (CPR), ongoing pregnancy (OPR), and live birth (LBR). RESULTS: For the primary analysis, 4 groups were created based on peak E2/mature oocyte ratio (group 1: <200, group 2: 200–300, group 3: 300–400, and group 4: >400 pg/mL/oocyte). After adjusting for age, basal FSH, and the number of mature oocytes, a significantly lower OPR was seen in group 4 as compared to group 1 (OR 0.15, 95% CI 0.03–0.86; p=0.032) and group 3 (OR 0.17, 95% CI 0.03–0.98; p=0.048), respectively. The adjusted LBR was also significantly lower in group 4 as compared to group 1 (OR 0.15, 95% CI 0.03–0.83; p=0.030). In a secondary analysis, 3 ranges of peak E2/ mature oocyte ratio (<200, 200–400, and >400 pg/ mL/oocyte) were compared between low, normal, and high responders (<6, 6–15, and >15 mature oocytes, respectively). Clinical pregnancy rate, OPR, and LBR were all lower in normal responders when the E2/oocyte ratio exceeded 400 pg/mL/oocyte as compared to <200 pg/mL/oocyte and 200–300 pg/mL/oocyte (CPR 1% vs. 16% and 32%, respectively, p=0.017; OPR 0 vs. 15% and 27%, respectively, p=0.011; and LBR 0 vs. 13% and 26%, respectively, p=0.018). CONCLUSION: Very elevated peak E2/mature oocyte ratio is associated with a lower CPR, OPR, and LBR in fresh, autologous, GnRH antagonist ICSI cycles.

Duke Scholars

Published In

Journal of Reproductive Medicine

ISSN

0024-7758

Publication Date

February 1, 2016

Volume

61

Issue

1

Start / End Page

11 / 16

Related Subject Headings

  • Obstetrics & Reproductive Medicine
  • 3215 Reproductive medicine
  • 3213 Paediatrics
  • 1114 Paediatrics and Reproductive Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sandoval, J. S., Steward, R. G., Chen, C., Li, Y. J., Price, T. M., & Muasher, S. J. (2016). High peak estradiol/mature oocyte ratio predicts lower clinical pregnancy, ongoing pregnancy, and live birth rates in GnRH antagonist intracytoplasmic sperm injection cycles. Journal of Reproductive Medicine, 61(1), 11–16.
Sandoval, J. S., R. G. Steward, C. Chen, Y. J. Li, T. M. Price, and S. J. Muasher. “High peak estradiol/mature oocyte ratio predicts lower clinical pregnancy, ongoing pregnancy, and live birth rates in GnRH antagonist intracytoplasmic sperm injection cycles.” Journal of Reproductive Medicine 61, no. 1 (February 1, 2016): 11–16.
Sandoval JS, Steward RG, Chen C, Li YJ, Price TM, Muasher SJ. High peak estradiol/mature oocyte ratio predicts lower clinical pregnancy, ongoing pregnancy, and live birth rates in GnRH antagonist intracytoplasmic sperm injection cycles. Journal of Reproductive Medicine. 2016 Feb 1;61(1):11–6.
Sandoval JS, Steward RG, Chen C, Li YJ, Price TM, Muasher SJ. High peak estradiol/mature oocyte ratio predicts lower clinical pregnancy, ongoing pregnancy, and live birth rates in GnRH antagonist intracytoplasmic sperm injection cycles. Journal of Reproductive Medicine. 2016 Feb 1;61(1):11–16.

Published In

Journal of Reproductive Medicine

ISSN

0024-7758

Publication Date

February 1, 2016

Volume

61

Issue

1

Start / End Page

11 / 16

Related Subject Headings

  • Obstetrics & Reproductive Medicine
  • 3215 Reproductive medicine
  • 3213 Paediatrics
  • 1114 Paediatrics and Reproductive Medicine